Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025)

Historic EBT Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 8.7%.

  • Eton Pharmaceuticals' EBT Margin fell 135600.0% to 8.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.83%, marking a year-over-year decrease of 25400.0%. This contributed to the annual value of 9.76% for FY2024, which is 75800.0% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' EBT Margin stood at 8.7%, which was down 135600.0% from 13.31% recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' EBT Margin ranged from a high of 43.0% in Q1 2021 and a low of 786.32% during Q3 2021
  • For the 5-year period, Eton Pharmaceuticals' EBT Margin averaged around 69.87%, with its median value being 10.18% (2024).
  • The largest annual percentage gain for Eton Pharmaceuticals' EBT Margin in the last 5 years was 235842700bps (2021), contrasted with its biggest fall of 2000000000bps (2021).
  • Over the past 5 years, Eton Pharmaceuticals' EBT Margin (Quarter) stood at 17.05% in 2021, then crashed by -37bps to 10.73% in 2022, then plummeted by -163bps to 6.74% in 2023, then surged by 35bps to 4.39% in 2024, then tumbled by -98bps to 8.7% in 2025.
  • Its EBT Margin was 8.7% in Q3 2025, compared to 13.31% in Q2 2025 and 83.87% in Q1 2025.